Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants

Brain

Volumn 133, Issue 9, 2010, Pages 2664-2676

  Fasano, Alfonso ^a   Romito, Luigi M ^b   Daniele, Antonio ^a   Piano, Carla ^a   Zinno, Massimiliano ^a   Bentivoglio, Anna Rita ^a   Albanese, Alberto ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

cognition; DBS; motor; Parkinson's disease; postural control

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

ADULT; ANXIETY; APATHY; APRAXIA; ARTICLE; BLEPHAROSPASM; BODY POSTURE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COGNITION; DEATH; DEMENTIA; DEPRESSION; DISEASE COURSE; DYSARTHRIA; DYSPHAGIA; DYSTONIA; EPISODIC MEMORY; FEMALE; GAIT; HEADACHE; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEMIPARESIS; HUMAN; HYPOPYON; IMPLANT; LUNG EMBOLISM; MALE; MANIC PSYCHOSIS; MOTOR PERFORMANCE; PARKINSON DISEASE; PHYSICAL PERFORMANCE; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SEIZURE; SEXUALITY; SPEECH; SPONDYLOSIS; TASK PERFORMANCE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE; VERBAL BEHAVIOR; WEIGHT REDUCTION; WOUND DEHISCENCE; AGED; COGNITION DISORDERS; COMPLICATION; GAIT DISORDERS, NEUROLOGIC; LONGITUDINAL STUDY; MIDDLE AGED; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SUBTHALAMIC NUCLEUS; SYNCOPE; TIME;

AGED; COGNITION DISORDERS; DEEP BRAIN STIMULATION; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SUBTHALAMIC NUCLEUS; SYNCOPE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77956374152     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq221     Document Type: Article

References (65)

1. Albanese A, Piacentini S, Romito LM, Leone M, Franzini A, Broggi G, et al. Suicide after successful deep brain stimulation for movement disorders. Neurology 2005; 65: 499-500.
2. Amboni M, Cozzolino A, Longo K, Picillo M, Barone P. Freezing of gait and executive functions in patients with Parkinson's disease. Mov Disord 2008; 23: 395-400.
3. American Psychiatric Association. DSM-IV-TR Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2000.
4. Ardouin C, Pillon B, Peiffer E, Bejjani P, Limousin P, Damier P, et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999; 46: 217-223
5. Ashburn A, Stack E, Pickering RM, Ward CD. A community dwelling sample of people with Parkinson's disease: characteristics of fallers and non-fallers. Age Ageing 2001; 30: 47-52. (Pubitemid 32288234)
6. Bejjani BP, Arnulf I, Demeret S, Damier P, Bonnet AM, Houeto JL, et al. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible? Ann Neurol 2000a; 47: 655-658
7. Bejjani BP, Gervais D, Arnulf I, Papadopoulos S, Demeret S, Bonnet AM, et al. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2000b; 68: 595-600.
8. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopami-nergic lesions? Neurology 1987; 37: 1539-1542
9. Braak H, Del Tredici K. Invited article: nervous system pathology in sporadic Parkinson disease. Neurology 2008; 70: 1916-1925
10. Charles PD, Van Blercom N, Krack P, Lee SL, Xie J, Besson G, et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002; 59: 932-934
11. Contarino MF, Daniele A, Sibilia AH, Romito LMA, Bentivoglio AR, Gainotti G, et al. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 248-252
12. Czernecki V, Schü pbach M, Yaici S, Lévy R, Bardinet E, Yelnik J, et al. Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord 2008; 23: 964-969
13. Daniele A, Albanese A, Contarino MF, Zinzi P, Barbier A, Gasparini F, et al. Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74: 175-182
14. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999; 14: 572-584
15. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schä fer H, Bö tzel K, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908. (Pubitemid 44315982)
16. Devos D, Defebvre L, Bordet R. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease. Fundam Clin Pharmacol 2010. Advance Access published on February 12, 2010, doi: 10.1111/j.1472-8206.2009.00798.x.
17. Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. UPDRS Development Committee. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan; 1987. p. 153-163
18. Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 834-839
19. Gervais-Bernard H, Xie-Brustolin J, Mertens P, Polo G, Klinger H, Adamec D, et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J Neurol 2009; 256: 225-233
20. Giladi N, Hausdorff JM. The role of mental function in the pathogenesis of freezing of gait in Parkinson's disease. J Neurol Sci 2006; 248: 173-176
21. Guehl D, Dehail P, de Sèze MP, Cuny E, Faux P, Tison F, et al. Evolution of postural stability after subthalamic nucleus stimulation in Parkinson's disease: a combined clinical and posturometric study. Exp Brain Res 2006; 170: 206-215
22. Herzog J, Volkmann J, Krack P, Kopper F, Pö tter M, Lorenz D, et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord 2003; 18: 1332-1337 (Pubitemid 38263319)
23. Hilker R, Portman AT, Voges J, Staal MJ, Burghaus L, van Laar T, et al. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 2005; 76: 1217-1221
24. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184
25. Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RH, et al. A 10-years study of incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000; 54: 1596-1602
26. Klawans HL. Individual manifestations of Parkinson's disease after ten or more years of levodopa. Mov Disord 1986; 1: 187-192
27. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21 (Suppl 14): S290-304.
28. Koss AM, Alterman RL, Tagliati M, Shils JL. Calculating total electrical energy delivered by deep brain stimulation systems. Ann Neurol 2005; 58: 168-169
29. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934 (Pubitemid 37409709)
30. Krack P, Fraix V, Mendes A, Benabid AL, Pollak P. Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov Disord 2002; 17 (Suppl 3): 188-197
31. Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, et al. Deep brain stimulation: preoperative issues. Mov Disord 2006; 21 (Suppl 14): 171-196
32. Limousin P, Martinez-Torres I. Deep brain stimulation for Parkinson's disease. Neurotherapeutics 2008; 5: 309-319
33. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, et al. Effect of parkinsonian signs and symptoms of bilateral subtha-lamic nucleus stimulation. Lancet 1995; 345: 91-95
34. Marchese R, Bove M, Abruzzese G. Effect of cognitive and motor tasks on postural stability in Parkinson's Disease: a posturographic study. Movement Disorders 2003; 18: 652-658
35. Matison R, Mayeux R, Rosen J, Fahn S. "Tip-of-the-tongue" phenomenon in Parkinson disease. Neurology 1982; 32: 567-570
36. Mesnage V, Houeto JL, Welter ML, Agid Y, Pidoux B, Dormont D, et al. Parkinson's disease: neurosurgery at an earlier stage? J Neurol Neurosurg Psychiatry 2002; 73: 778-779
37. Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 1999; 53: 85-90.
38. Morris M, Iansek R, Smithson F, Huxham F. Postural instability in Parkinson's disease: a comparison with and without a concurrent task. Gait Posture 2000; 12: 205-216
39. Oueslati A, Sgambato-Faure V, Melon C, Kachidian P, Gubellini P, Amri M, et al. High-frequency stimulation of the subthalamic nucleus potentiates L-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease. J Neurosci 2007; 27: 2377-2386
40. Pahwa R, Wilkinson SB, Overman J, Lyons KE. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease. Stereotact Funct Neurosurg 2005; 83: 80-83
41. Piboolnurak P, Lang AE, Lozano AM, Miyasaki JM, Saint-Cyr JA, Poon YY, et al. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Mov Disord 2007; 22: 990-997
42. Pillon B, Ardouin C, Damier P, Krack P, Houeto JL, Klinger H, et al. Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology 2000; 55: 411-418
43. Pollak P, Benabid AL, Limousin P, Benazzouz A, Hoffmann D, Le Bas JF, et al. Subthalamic nucleus stimulation alleviates akinesia and rigidity in parkinsonian patients. Adv Neurol 1996; 69: 591-594
44. Romito LM, Contarino MF, Vanacore N, Bentivoglio AR, Scerrati M, Albanese A. Replacement of dopaminergic medication with subthala-mic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord 2009; 24: 557-563
45. Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P, Albanese A. Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology 2002; 58: 1546-1550
46. Russmann H, Ghika J, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology 2004; 63: 1952-1954
47. Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000; 15: 1112-1118
48. Schroeder U, Kuehler A, Lange KW, Haslinger B, Tronnier VM, Krause M, et al. Subthalamic nucleus stimulation affects a frontotem-poral network: a PET study. Ann Neurol 2003; 54: 445-450
49. Schü pbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005; 76: 1640-1644
50. Schü pbach WM, Maltête D, Houeto JL, du Montcel ST, Mallet L, Welter ML, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology 2007; 68: 267-271
51. Simonin C, Tir M, Devos D, Kreisler A, Dujardin K, Salleron J, et al. Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon. J Neurol 2009; 256: 1736-1741
52. Stolze H, Klebe S, Poepping M, Lorenz D, Herzog J, Hamel W, et al. Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait. Neurology 2001; 57: 144-146
53. Temperli P, Ghika J, Villemure JG, Burkhard PR, Bogousslavsky J, Vingerhoets FJ. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology 2003; 60: 78-81.
54. Trepanier LL, Saint-Cyr JA, Lozano AM, Lang AE. Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease. Neurology 1998; 51: 207-215
55. Troster AI, Woods SP, Fields JA. Verbal fluency declines after pallidot-omy: an interaction between task and lesion laterality. Appl Neuropsychol 2003; 10: 69-75.
56. Volkmann J, Herzog J, Kopper F, Deuschl G. Introduction to the programming of deep brain stimulators. Mov Disord 2002; 17(Suppl 3): 181-187
57. Voon V, Krack P, Lang AE, Lozano AM, Dujardin K, Schü pbach M, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008; 131: 2720-2728
58. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009; 301: 63-73.
59. Welter ML, Houeto JL, Tezenas du Montcel S, Mesnage V, Bonnet AM, Pillon B, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002; 125: 575-583 (Pubitemid 34194412)
60. Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord 2008; 14: 114-119
61. Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605-614
62. Yogev G, Giladi N, Peretz C, Springer S, Simon ES, Hausdorff JM. Dual tasking, gait rhythmicity, and Parkinson's disease: which aspects of gait are attention demanding? Eur J Neurosci 2005; 22: 1248-1256
63. Zangaglia R, Pacchetti C, Pasotti C, Mancini F, Servello D, Sinforiani E, et al. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study. Mov Disord 2009; 24: 1621-1628
64. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-379
65. Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70.